DOSE-RELATED INVERSION OF CINNARIZINE AND FLUNARIZINE EFFECTS ON MITOCHONDRIAL PERMEABILITY TRANSITION

Citation
A. Elimadi et al., DOSE-RELATED INVERSION OF CINNARIZINE AND FLUNARIZINE EFFECTS ON MITOCHONDRIAL PERMEABILITY TRANSITION, European journal of pharmacology, 348(1), 1998, pp. 115-121
Citations number
31
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00142999
Volume
348
Issue
1
Year of publication
1998
Pages
115 - 121
Database
ISI
SICI code
0014-2999(1998)348:1<115:DIOCAF>2.0.ZU;2-T
Abstract
We investigated the effects of cinnarizine and flunarizine on mitochon drial permeability transition, ATP synthesis, membrane potential and N AD(P)H oxidation. Both drugs were effective in inhibiting the mitochon drial permeability transition induced either by Ca2+ alone or in the p resence of tert-butylhydroperoxide. This protective effect occurred at low concentrations (< 50 mu M) of these drugs and was accompanied by the inhibition of NAD(P)H oxidation and the restoration of the mitocho ndrial membrane potential decreased by a high concentration of Ca2+ (2 5 mu M). However, at higher concentrations (> 50 mu M) Of cinnarizine and flunarizine and in the absence of both tert-butylhydroperoxide and Ca2+, their effects on the mitochondria were reversed as follows: mit ochondrial permeability transition was generated, mitochondrial NAD(P) H was oxidized and membrane potential collapsed. These deleterious eff ects were not antagonized by cyclosporine A, the most potent inhibitor of the mitochondrial permeability transition, but by 2,6-di-rert-buty l-4-methylphenol, a known antioxidant agent. This mitochondrial effect was neither accompanied by an increase in malondialdehyde production nor by an increase in H2O2 generation, which attested that the effect of both drugs was not due to an increase in reactive oxygen species pr oduction. The dual effects of both cinnarizine and flunarizine on mito chondrial functions is discussed with regard to both the protective ef fect afforded by these drugs against ischemia-reperfusion injury and t heir side effect observed in some therapeutic situations where an over dosage seems likely. (C) 1998 Elsevier Science B.V.